Cargando…

Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report

Atypical hemolytic uremic syndrome (aHUS), also called complement-mediated hemolytic uremic syndrome (CM-HUS), is a rare disease caused by dysregulation in the alternative complement activation pathway. It is a life-threatening condition causing ischemia of a number of organs, and it typically cause...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rysava, Romana, Peiskerova, Martina, Tesar, Vladimir, Benes, Jan, Kment, Martin, Szilágyi, Ágnes, Csuka, Dorottya, Prohászka, Zoltán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580272/ https://www.ncbi.nlm.nih.gov/pubmed/36275662 http://dx.doi.org/10.3389/fimmu.2022.1001366

Ejemplares similares

Analysis of Linear Antibody Epitopes on Factor H and CFHR1 Using Sera of Patients with Autoimmune Atypical Hemolytic Uremic Syndrome
por: Trojnár, Eszter, et al.
Publicado: (2017)

A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report
por: Pollack, Shirley, et al.
Publicado: (2021)

The Major Autoantibody Epitope on Factor H in Atypical Hemolytic Uremic Syndrome Is Structurally Different from Its Homologous Site in Factor H-related Protein 1, Supporting a Novel Model for Induction of Autoimmunity in This Disease
por: Bhattacharjee, Arnab, et al.
Publicado: (2015)

MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy
por: Petr, Vojtech, et al.
Publicado: (2022)

Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature
por: Matošević, Matija, et al.
Publicado: (2023)

First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis
por: Szarvas, Nóra, et al.
Publicado: (2014)

COVID-19 vaccination and Atypical hemolytic uremic syndrome
por: Bouwmeester, Romy N., et al.
Publicado: (2022)

Atypical hemolytic uremic syndrome triggered by varicella infection
por: Condom, Pauline, et al.
Publicado: (2017)

Anti-factor H antibody and its role in atypical hemolytic uremic syndrome
por: Raina, Rupesh, et al.
Publicado: (2022)

Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)

Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)

Atypical Hemolytic Uremic Syndrome After Liver Transplant Treated With Eculizumab
por: Bhatti, Sundus, et al.
Publicado: (2020)

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
por: Gómez Delgado, Irene, et al.
Publicado: (2021)

Case report - atypical hemolytic uremic syndrome triggered by influenza B
por: Kobbe, Robin, et al.
Publicado: (2017)

Pathogenesis of Atypical Hemolytic Uremic Syndrome
por: Yoshida, Yoko, et al.
Publicado: (2019)

The genetics of atypical hemolytic uremic syndrome
por: Feitz, Wouter J. C., et al.
Publicado: (2018)

How atypical can Atypical Hemolytic Uremic Syndrome be?
por: Sajan, Thomas, et al.
Publicado: (2014)

Atypical Hemolytic and Uremic Syndrome Triggered by Infection With SARS-CoV2
por: Kaufeld, Jessica, et al.
Publicado: (2021)

Decreased Ficolin-3-mediated Complement Lectin Pathway Activation and Alternative Pathway Amplification During Bacterial Infections in Patients With Type 2 Diabetes Mellitus
por: Barkai, László József, et al.
Publicado: (2019)

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
por: Piras, Rossella, et al.
Publicado: (2023)

The Rationale of Complement Blockade of the MCP(ggaac) Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review
por: Turudic, Daniel, et al.
Publicado: (2023)

Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R
por: Cserhalmi, Marcell, et al.
Publicado: (2017)

Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome
por: Saad, Antonio F., et al.
Publicado: (2016)

Complement and the atypical hemolytic uremic syndrome in children
por: Loirat, Chantal, et al.
Publicado: (2008)

Pediatric Atypical Hemolytic Uremic Syndrome Advances
por: Raina, Rupesh, et al.
Publicado: (2021)

A Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Review
por: Turudic, Daniel, et al.
Publicado: (2022)

Campylobacter Colitis as a Trigger for Atypical Hemolytic Uremic Syndrome: About One Case
por: Quinaux, Thomas, et al.
Publicado: (2023)

Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database
por: Puraswani, Mamta, et al.
Publicado: (2019)

Atypical Hemolytic Uremic Syndrome-Associated FHR1 Isoform FHR1*B Enhances Complement Activation and Inflammation
por: Xu, Boyang, et al.
Publicado: (2022)

Functional Analysis of Variants in Complement Factor I Identified in Age-Related Macular Degeneration and Atypical Hemolytic Uremic Syndrome
por: de Jong, Sarah, et al.
Publicado: (2022)

Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report
por: Kronbichler, Andreas, et al.
Publicado: (2014)

Assesment, Treatment and Prevention of Atypical Hemolytic Uremic Syndrome
por: Nickavar, Azar, et al.
Publicado: (2013)

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016)

Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018)

Atypical Hemolytic Uremic Syndrome: A Case Report
por: Mohammed, Sohaib K, et al.
Publicado: (2019)

Atypical Hemolytic Uremic Syndrome: A Brief Review
por: Zhang, Kuixing, et al.
Publicado: (2017)

Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab
por: Ebrahem, Rawaa, et al.
Publicado: (2017)

Atypical hemolytic uremic syndrome: a case report
por: Basnayake, B. M. D. B., et al.
Publicado: (2020)

Atypical Hemolytic Uremic Syndrome: Genetic Landscape Challenge
por: Valiña, Laura, et al.
Publicado: (2019)

Rare Presentation of Atypical Hemolytic Uremic Syndrome in an Adult
por: Alhabhbeh, Ammar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fq9hvho59srp5tgo6349qpco39